Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
282
-
Total 13F shares, excl. options
-
36.9M
-
Shares change
-
-444K
-
Total reported value, excl. options
-
$4.46B
-
Value change
-
-$52.5M
-
Put/Call ratio
-
1.04
-
Number of buys
-
135
-
Number of sells
-
-114
-
Price
-
$120.89
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q3 2017
303 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q3 2017.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 282 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.9M shares
of 152M outstanding shares and own 24.2% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.58M shares), VANGUARD GROUP INC (3.1M shares), BROWN CAPITAL MANAGEMENT LLC (2.12M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.95M shares), Neuberger Berman Group LLC (1.78M shares), Select Equity Group, L.P. (1.71M shares), BAMCO INC /NY/ (1.52M shares), Mairs & Power INC (1.44M shares), JANUS HENDERSON GROUP PLC (1.12M shares), and STATE STREET CORP (994K shares).
This table shows the top 282 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.